The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on
The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes
β Scribed by Cam Donaldson; Stephen Birch; Amiram Gafni
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 184 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.642
No coin nor oath required. For personal study only.
β¦ Synopsis
To date, a common view in the health economics literature is that the applicability of cost-benefit analysis (CBA) is limited, due to the distribution problem which underlies its main method of valuation (e.g. willingness to pay). One view is that cost effectiveness analysis (CEA) overcomes these problems. We show that the same distributional concerns apply to non-monetary valuations of health consequences, to measurement of costs and to the decision rules of CEA. Hence adopting CEA over CBA cannot be justified on the basis of "avoiding" distributional considerations. The implications of our results are discussed, including alternative strategies for the use of "income-based" research findings in social decision-making.
π SIMILAR VOLUMES
## Abstract We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive βeffort.β This method could be used within a costβeffectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatmen
## Abstract Using data from the Health and Retirement Survey and the Assets and Health Dynamics of the Oldest Old survey, we estimate the stochastic process that determines both the distribution and dynamics of health care costs. We find that the dataβgenerating process for log health costs is well
## Abstract In the economic evaluation of health care programmes, productivity costs are often estimated using patients' wages for the period of absence. However, the use of such methods for short periods of absence is controversial. A previous study found that shortβterm absence is often compensat
Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i
## Abstract In this study, the convergent validity of the contingent valuation method (CVM) and travel cost method (TCM) is tested by comparing estimates of the willingness to pay (WTP) for improving access to mammographic screening in rural areas of Australia. It is based on a telephone survey of